RVNC
Revance Therapeutics, Inc.
RVNC
RVNC
Delisted
RVNC was delisted on the 5th of February, 2025.
69 hedge funds and large institutions have $334M invested in Revance Therapeutics, Inc. in 2014 Q4 according to their latest regulatory filings, with 12 funds opening new positions, 32 increasing their positions, 14 reducing their positions, and 23 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
48% less first-time investments, than exits
New positions opened: 12 | Existing positions closed: 23
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $46K
Holders
69
Holding in Top 10
2
Calls
–
Puts
$46K
Top Buyers
| 1 | +$23.2M | |
| 2 | +$16.9M | |
| 3 | +$15.9M | |
| 4 |
PC
Polar Capital
London,
United Kingdom
|
+$7.07M |
| 5 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$5.32M |
Top Sellers
| 1 | -$19.9M | |
| 2 | -$10.9M | |
| 3 | -$8.15M | |
| 4 |
PHS
PFM Health Sciences
San Francisco,
California
|
-$7.51M |
| 5 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
-$5.38M |